83 Olaparib in patients with biallelic BRCA1/2 inactivation 14 Carboplatinum + paclitaxel PD Selinexor PD 15 Gosereline NE Docetaxel NE Bicalutamide PD Docetaxel NE Abiraterone PD Cabazitaxel + Carboplatin PR 16 Adriamycine + cyclophosphamide n/a (adjuvant) Docetaxel n/a (adjuvant) Capecitabine PR Carboplatinum + gemcitabine PR Low dose cisplatinum NE Nivolumab SD 17 Capecitabine + oxaliplatin unknown Irinotecan unknown Panitumumab unknown 18 Bicalutamide NE Enzalutamide SD Docetaxel PD Cabazitaxel PD Gosereline NE 19 5-Fluorouracil + irinotecan + oxaliplatin SD 20 5-Fluorouracil + irinotecan + oxaliplatin SD 21 Mitotane PD 22 Anastrozole PR 5-Fluorouracil + Cyclophosphamide + Doxorubicine PR Carboplatin + paclitaxel PD Capecitabine PD 23 Bicalutamide SD Docetaxel PD Radium-223 PD 24 Capecitabine + oxaliplatin n/a (adjuvant) 5-Fluorouracil + irinotecan + bevacizumab SD Capecitabine PR 25 Leuproreline n/a Docetaxel + dendritic cell vaccination PD Cabazitaxel + carboplatinum PR 26 Carboplatinum + paclitaxel CR Tamoxifen PD Carboplatinum + gemcitabine CR Bevacizumab SD Carboplatinum + liposomal doxorubicin PR 27 5-Fluorouracil + irinotecan + oxaliplatin SD 3
RkJQdWJsaXNoZXIy MTk4NDMw